Terms: = Lymphoma AND BCL7A, BCL7, 605, ENSG00000110987 AND Treatment
21 results:
1. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study.
Kang D; Kim S; Kim H; Lee M; Kong SY; Chang YJ; Sim SH; Kim YJ; Cho J
JMIR Public Health Surveill; 2023 Mar; 9():e44105. PubMed ID: 36884274
[TBL] [Abstract] [Full Text] [Related]
2. SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities.
Andrades A; Peinado P; Alvarez-Perez JC; Sanjuan-Hidalgo J; García DJ; Arenas AM; Matia-González AM; Medina PP
Mol Cancer; 2023 Feb; 22(1):39. PubMed ID: 36810086
[TBL] [Abstract] [Full Text] [Related]
3. Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin lymphoma.
Jones DA; Candio P; Shakir R; Ramroth J; Wolstenholme J; Gray AM; Cutter DJ; Ntentas G
Clin Oncol (R Coll Radiol); 2023 May; 35(5):301-310. PubMed ID: 36732121
[TBL] [Abstract] [Full Text] [Related]
4. Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk.
Usui Y; Iwasaki Y; Matsuo K; Endo M; Kamatani Y; Hirata M; Sugano K; Yoshida T; Matsuda K; Murakami Y; Maeda Y; Nakagawa H; Momozawa Y
Cancer Sci; 2022 Nov; 113(11):3972-3979. PubMed ID: 36065483
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
[TBL] [Abstract] [Full Text] [Related]
6. Recent malignant testicular tumor trend in Japan, a country with an aging population: a large-scale study of 2012-2015 hospital-based cancer registry data.
Kojo K; Kawai K; Kawahara T; Kimura T; Kandori S; Nagumo Y; Nitta S; Kojima T; Okuyama A; Higashi T; Nishiyama H
Jpn J Clin Oncol; 2020 Sep; 50(10):1201-1208. PubMed ID: 32627833
[TBL] [Abstract] [Full Text] [Related]
7. Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin lymphoma: A Children's Oncology Group Study.
Kahn JM; Kelly KM; Pei Q; Bush R; Friedman DL; Keller FG; Bhatia S; Henderson TO; Schwartz CL; Castellino SM
J Clin Oncol; 2019 Nov; 37(32):3009-3017. PubMed ID: 31539308
[TBL] [Abstract] [Full Text] [Related]
8. [The evaluation of modified cell infusion method to reduce febrile non-hemolytic transfusion reaction in CD(19) chimeric antigen receptor T cell threapy].
Wang J; Deng Q; Mu J; Jiang YY; Meng JX; Li YM
Zhonghua Nei Ke Za Zhi; 2019 Sep; 58(9):668-672. PubMed ID: 31461818
[No Abstract] [Full Text] [Related]
9. Optimal Time Points for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis on the Basis of European LeukemiaNet Recommendations in Chronic Myeloid Leukemia.
Yoo HL; Kim SH; Choi SY; Lee SE; Kim DW
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):406-412.e1. PubMed ID: 30928650
[TBL] [Abstract] [Full Text] [Related]
10. Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi.
Painschab MS; Westmoreland KD; Kasonkanji E; Zuze T; Kaimila B; Waswa P; El-Mallawany NK; Tomoka T; Mulenga M; Montgomery ND; Fedoriw Y; Gopal S
Blood Adv; 2019 Feb; 3(4):612-620. PubMed ID: 30796065
[TBL] [Abstract] [Full Text] [Related]
11. A peer review process as part of the implementation of clinical pathways in radiation oncology: Does it improve compliance?
Gebhardt BJ; Heron DE; Beriwal S
Pract Radiat Oncol; 2017; 7(5):332-338. PubMed ID: 28284760
[TBL] [Abstract] [Full Text] [Related]
12. Risk of premature menopause after treatment for Hodgkin's lymphoma.
Swerdlow AJ; Cooke R; Bates A; Cunningham D; Falk SJ; Gilson D; Hancock BW; Harris SJ; Horwich A; Hoskin PJ; Linch DC; Lister A; Lucraft HH; Radford J; Stevens AM; Syndikus I; Williams MV;
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25139687
[TBL] [Abstract] [Full Text] [Related]
13. Study of regulatory T-cells in patients with gastric malt lymphoma: influence on treatment response and outcome.
García M; Bellosillo B; Sánchez-González B; García-Payarols F; Seoane A; Ferrer AM; Gimeno E; Barranco LE; Torner A; Solé F; Besses C; Serrano S; Salar A
PLoS One; 2012; 7(12):e51681. PubMed ID: 23284739
[TBL] [Abstract] [Full Text] [Related]
14. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.
Xu H; Cheng C; Devidas M; Pei D; Fan Y; Yang W; Neale G; Scheet P; Burchard EG; Torgerson DG; Eng C; Dean M; Antillon F; Winick NJ; Martin PL; Willman CL; Camitta BM; Reaman GH; Carroll WL; Loh M; Evans WE; Pui CH; Hunger SP; Relling MV; Yang JJ
J Clin Oncol; 2012 Mar; 30(7):751-7. PubMed ID: 22291082
[TBL] [Abstract] [Full Text] [Related]
15. Unravelling the hidden heterogeneities of diffuse large B-cell lymphoma based on coupled two-way clustering.
Zhang W; Li L; Li X; Jiang W; Huo J; Wang Y; Lin M; Rao S
BMC Genomics; 2007 Sep; 8():332. PubMed ID: 17888167
[TBL] [Abstract] [Full Text] [Related]
16. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including bcl7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract] [Full Text] [Related]
17. Rituximab as treatment for refractory kidney transplant rejection.
Becker YT; Becker BN; Pirsch JD; Sollinger HW
Am J Transplant; 2004 Jun; 4(6):996-1001. PubMed ID: 15147435
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
Guay C; Lépine M; Verreault J; Bénard F
J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
[TBL] [Abstract] [Full Text] [Related]
19. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract] [Full Text] [Related]
20. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
van Besien K; Ha CS; Murphy S; McLaughlin P; Rodriguez A; Amin K; Forman A; Romaguera J; Hagemeister F; Younes A; Bachier C; Sarris A; Sobocinski KS; Cox JD; Cabanillas F
Blood; 1998 Feb; 91(4):1178-84. PubMed ID: 9454747
[TBL] [Abstract] [Full Text] [Related]
[Next]
